BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22329457)

  • 21. Multiple subcutaneous granular-cell tumours in a patient with Noonan syndrome.
    Lohmann DR; Gillessen-Kaesbach G
    Clin Dysmorphol; 2000 Oct; 9(4):301-2. PubMed ID: 11045593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutation analysis of PTPN11 gene in Noonan syndrome].
    Yang T; Meng Y; Shi HP; Zhao SM; Wang G; Huang SZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):554-8. PubMed ID: 20931536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation.
    Yoshida R; Ogata T; Masawa N; Nagai T
    Pediatr Blood Cancer; 2008 Jun; 50(6):1274-6. PubMed ID: 18253957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noonan syndrome: rhGH treatment and PTPN11 mutation.
    Wu X; Wu J; Yuan Y; Yang L; Yu L
    Mol Genet Genomic Med; 2023 Nov; 11(11):e2266. PubMed ID: 37525886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mother and son with Noonan syndrome resulting from a PTPN11 mutation: first report of molecularly proven cases from Turkey.
    Demir K; Yntema HG; Altincik A; Böber E
    Turk J Pediatr; 2010; 52(3):321-4. PubMed ID: 20718194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline KRAS mutations cause Noonan syndrome.
    Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
    Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilocytic astrocytoma in a child with Noonan syndrome.
    Schuettpelz LG; McDonald S; Whitesell K; Desruisseau DM; Grange DK; Gurnett CA; Wilson DB
    Pediatr Blood Cancer; 2009 Dec; 53(6):1147-9. PubMed ID: 19621452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
    Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
    Padidela R; Camacho-Hübner C; Attie KM; Savage MO
    Horm Res; 2008; 70(3):129-36. PubMed ID: 18663312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mother and son with Noonan syndrome resulting from a PTPN11 mutation.
    Derbent M
    Turk J Pediatr; 2011; 53(1):117; author reply 118. PubMed ID: 21534355
    [No Abstract]   [Full Text] [Related]  

  • 32. Granular cell tumor on the sole of a child: a case report.
    López V; Santonja N; Jordá E
    Pediatr Dermatol; 2011; 28(4):473-4. PubMed ID: 21793893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Noonan syndrome: a case report and literature review].
    Chen J; Yang Y; Tan Z; Wang Y; Tang X; Gong Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1261-5. PubMed ID: 20045924
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic and pathogenetic aspects of Noonan syndrome and related disorders.
    Zenker M
    Horm Res; 2009 Dec; 72 Suppl 2():57-63. PubMed ID: 20029240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.
    Sznajer Y; Keren B; Baumann C; Pereira S; Alberti C; Elion J; Cavé H; Verloes A
    Pediatrics; 2007 Jun; 119(6):e1325-31. PubMed ID: 17515436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
    Araki T; Mohi MG; Ismat FA; Bronson RT; Williams IR; Kutok JL; Yang W; Pao LI; Gilliland DG; Epstein JA; Neel BG
    Nat Med; 2004 Aug; 10(8):849-57. PubMed ID: 15273746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
    Tidyman WE; Rauen KA
    Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors.
    Mutesa L; Pierquin G; Janin N; Segers K; Thomée C; Provenzi M; Bours V
    Cancer Genet Cytogenet; 2008 Apr; 182(1):40-2. PubMed ID: 18328949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orthopaedic conditions in Ras/MAPK related disorders.
    Reinker KA; Stevenson DA; Tsung A
    J Pediatr Orthop; 2011; 31(5):599-605. PubMed ID: 21654472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.